UBS Group AG Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on March 3, 2020, serves as a report of a foreign private issuer pursuant to Rule 13a-16 under the Securities Exchange Act of 1934. The filing contains a description of the rights of each class of securities of UBS Group AG and UBS AG registered under Section 12 of the Exchange Act as of December 31, 2019. The document details the terms of ordinary shares, medium-term notes (Series A and B), and various Exchange Traded Notes (ETNs) and E-TRACS products.
Key Financial Metrics
The filing text does not provide consolidated financial performance metrics such as revenue, profit, cash flow, or margins for the period ended December 31, 2019. Instead, it focuses on the structural terms of outstanding securities. Key data points include:
- Share Capital: As of year-end 2019, UBS Group AG had 3,859,055,395 issued shares with a par value of CHF 0.10 each, resulting in a share capital of CHF 385,905,539.50.
- Debt Securities: The filing outlines the terms for Medium-Term Notes Series A and Series B, which may be issued in various currencies (primarily U.S. dollars) and include fixed, floating, and indexed rates. Specific principal amounts for individual ETN series range from $50 million to $1.25 billion.
- Liquidity and Debt: No aggregate debt or liquidity figures are provided in this specific exhibit. The document describes the mechanics of redemption, defeasance, and default rather than the company's current balance sheet position.
Material Changes
The filing does not report material changes in financial performance compared to prior periods. It is a static description of security rights and terms effective as of December 31, 2019. The document notes that UBS Switzerland AG became a co-obligor for certain debt securities previously issued by UBS AG following a transfer of the Retail & Corporate and Wealth Management business.
Guidance, Outlook, and Risks
The filing contains no management guidance or outlook regarding future earnings or strategic direction. However, it details significant risks associated with the specific securities described:
- Investment Risk: ETNs and E-TRACS products do not pay interest and do not guarantee the return of principal. Investors may lose some or all of their investment if the underlying index declines or fails to offset accrued fees.
- Fee Structures: Securities are subject to tracking fees (ranging from 0.30% to 0.95% per annum) and financing charges that accrue daily, reducing the final payment amount.
- Acceleration and Call Rights: UBS retains the right to redeem certain securities (Call Right) or accelerate maturity if the indicative value falls to a specified "Floor Level" (e.g., $20.00 for certain ETNs).
- Market Disruption: Calculation agents have discretion to postpone valuation dates or estimate index levels in the event of market disruptions, which may adversely affect security values.
- Default Remedies: In the event of default, the "default amount" payable is determined by the cost of having a qualified financial institution assume the obligations, which may differ from the principal amount.
Important Facts for Investor Verification
- Verify the specific terms of any held ETN or E-TRACS, as redemption amounts are calculated based on index performance minus accrued fees, with no principal guarantee.
- Confirm the "Floor Level" for leveraged ETNs, as breaching this threshold triggers mandatory acceleration and redemption.
- Note that UBS Switzerland AG is a co-obligor for specific debt securities, while other securities are obligations solely of UBS AG.
- Understand that the Calculation Agent (often UBS Securities LLC) has sole discretion in determining index levels and market disruption events, with determinations being final and binding absent manifest error.
- Recognize that this filing describes security rights as of December 31, 2019, and does not contain the company's audited financial statements for that period.